{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:38:21Z","timestamp":1790563101988,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Systemic corticosteroids are often used to treat inflammatory bowel disease (IBD) flares during pregnancy as maintenance of disease remission is crucial to optimize pregnancy outcomes. However, there is little data regarding the effect of in utero exposure to corticosteroids on the risk of adverse birth outcomes and early-life infections in the offspring.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used the Danish national registries to establish a nationwide cohort of all singleton live births in women with IBD from 1995 to 2015. Outcomes in children exposed in utero to corticosteroids were compared to those who were not exposed. In logistic and Cox proportional hazard regression models, we adjusted the outcomes (major congenital malformation, preterm birth, small for gestational age, low 5-min Apgar score, and infections) for confounders such as body mass index, smoking, comorbidity, and additional medical IBD treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After in utero exposure to corticosteroids at any time between 30\u00a0days prior to conception through the first trimester (<jats:italic>n<\/jats:italic>\u2009=\u2009707), the adjusted hazard ratio of major congenital malformation was 1.28 (95% CI: 0.82\u20132.00) compared to children born to women with IBD, but not exposed to corticosteroids in utero (<jats:italic>n<\/jats:italic>\u2009=\u20099371). After in utero exposure to corticosteroids at any time during pregnancy (<jats:italic>n<\/jats:italic>\u2009=\u20091336), the adjusted odds ratios for preterm birth, small for gestational age, and low 5-min Apgar score were 2.45 (95% CI: 1.91\u20133.13), 1.21 (95% CI: 0.76\u20131.90), and 0.91 (95% CI: 0.33\u20132.52), respectively. Finally, the adjusted hazard ratio of overall infections in the first year of life was 1.14 (95% CI: 0.94\u20131.39).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This nationwide cohort study suggests that children of women with IBD exposed to corticosteroids in utero had an almost 2.5-fold increased risk of preterm birth. Use of corticosteroids is closely related to disease activity and we cannot adjust for the independent role of disease activity. It is however reassuring that the other examined birth and early-life outcomes were not statistically significantly increased.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-023-02817-7","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T10:04:28Z","timestamp":1681293868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7433-7656","authenticated-orcid":false,"given":"Line Riis","family":"J\u00f8lving","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7634-6812","authenticated-orcid":false,"given":"Jan","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4598-8679","authenticated-orcid":false,"given":"Mette Louise","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2720-4404","authenticated-orcid":false,"given":"Sonia","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-3033","authenticated-orcid":false,"given":"Bente Mertz","family":"N\u00f8rg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"issue":"2","key":"2817_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/ecco-jcc\/jju006","volume":"9","author":"CJ van der Woude","year":"2015","unstructured":"van der Woude CJ, Ardizzone S, Bengtson MB, Fiorino G, Fraser G, Katsanos K, et al. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis. 2015;9(2):107\u201324.","journal-title":"J Crohns Colitis"},{"issue":"2","key":"2817_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/03009740903449313","volume":"39","author":"K Mitchell","year":"2010","unstructured":"Mitchell K, Kaul M, Clowse ME. The management of rheumatic diseases in pregnancy. Scand J Rheumatol. 2010;39(2):99\u2013108.","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"2817_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/14740338.2021.1873948","volume":"20","author":"R Laube","year":"2021","unstructured":"Laube R, Paramsothy S, Leong RW. Use of medications during pregnancy and breastfeeding for Crohn\u2019s disease and ulcerative colitis. Expert Opin Drug Saf. 2021;20(3):275\u201392.","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"2817_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00005237-200209000-00004","volume":"16","author":"DC McGee","year":"2002","unstructured":"McGee DC. Steroid use during pregnancy. J Perinat Neonatal Nurs. 2002;16(2):26\u201339.","journal-title":"J Perinat Neonatal Nurs"},{"issue":"6","key":"2817_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","volume":"62","author":"L Park-Wyllie","year":"2000","unstructured":"Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62(6):385\u201392.","journal-title":"Teratology"},{"issue":"6","key":"2817_CR6","doi-asserted-by":"publisher","first-page":"585 e1 7","DOI":"10.1016\/j.ajog.2007.05.046","volume":"197","author":"SL Carmichael","year":"2007","unstructured":"Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ, et al. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007;197(6):585 e1 7 (discussion 683-4, e1-7).","journal-title":"Am J Obstet Gynecol."},{"issue":"1","key":"2817_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.reprotox.2003.10.007","volume":"18","author":"C Gur","year":"2004","unstructured":"Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol. 2004;18(1):93\u2013101.","journal-title":"Reprod Toxicol"},{"issue":"4","key":"2817_CR8","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1542\/peds.8.4.527","volume":"8","author":"FC Fraser","year":"1951","unstructured":"Fraser FC, Fainstat TD. Production of congenital defects in the off-spring of pregnant mice treated with cortisone; progress report. Pediatrics. 1951;8(4):527\u201333.","journal-title":"Pediatrics"},{"issue":"6","key":"2817_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00431-020-03593-9","volume":"179","author":"Y Gutbir","year":"2020","unstructured":"Gutbir Y, Wainstock T, Sheiner E, Segal I, Sergienko R, Landau D, et al. Low Apgar score in term newborns and long-term infectious morbidity: a population-based cohort study with up to 18 years of follow-up. Eur J Pediatr. 2020;179(6):959\u201371.","journal-title":"Eur J Pediatr"},{"key":"2817_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2393-9-14","volume":"9","author":"V Ehrenstein","year":"2009","unstructured":"Ehrenstein V, Pedersen L, Grijota M, Nielsen GL, Rothman KJ, Sorensen HT. Association of Apgar score at five minutes with long-term neurologic disability and cognitive function in a prevalence study of Danish conscripts. BMC Pregnancy Childbirth. 2009;9:14.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"7","key":"2817_CR11","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/j.1572-0241.2007.01216.x","volume":"102","author":"B Norgard","year":"2007","unstructured":"Norgard B, Pedersen L, Christensen LA, Sorensen HT. Therapeutic drug use in women with Crohn\u2019s disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol. 2007;102(7):1406\u201313.","journal-title":"Am J Gastroenterol"},{"key":"2817_CR12","doi-asserted-by":"crossref","unstructured":"Odufalu FD, Long M, Lin K, Mahadevan U, Crohn's PIft, Colitis Foundation Clinical Research Alliance recruited patients for their respective centers for participant e. Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry. Gut. 2021.","DOI":"10.1136\/gutjnl-2021-325317"},{"issue":"12","key":"2817_CR13","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1080\/00365521.2016.1208269","volume":"51","author":"G Broms","year":"2016","unstructured":"Broms G, Granath F, Stephansson O, Kieler H. Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment. Scand J Gastroenterol. 2016;51(12):1462\u20139.","journal-title":"Scand J Gastroenterol"},{"issue":"5462","key":"2817_CR14","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1126\/science.287.5462.2398","volume":"287","author":"FL Epidemiology","year":"2000","unstructured":"Epidemiology FL. When an entire country is a cohort. Science. 2000;287(5462):2398\u20139.","journal-title":"Science"},{"key":"2817_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2147\/CLEP.S179083","volume":"11","author":"M Schmidt","year":"2019","unstructured":"Schmidt M, Schmidt SAJ, Adelborg K, Sundboll J, Laugesen K, Ehrenstein V, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563\u201391.","journal-title":"Clin Epidemiol"},{"issue":"8","key":"2817_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541\u20139.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"2817_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10654-018-0356-1","volume":"33","author":"M Bliddal","year":"2018","unstructured":"Bliddal M, Broe A, Pottegard A, Olsen J, Langhoff-Roos J. The Danish Medical Birth Register. Eur J Epidemiol. 2018;33(1):27\u201336.","journal-title":"Eur J Epidemiol"},{"key":"2817_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u201390.","journal-title":"Clin Epidemiol"},{"issue":"3","key":"2817_CR19","first-page":"798-f","volume":"46","author":"A Pottegard","year":"2017","unstructured":"Pottegard A, Schmidt SAJ, Wallach-Kildemoes H, Sorensen HT, Hallas J, Schmidt M. Data Resource Profile: The Danish National Prescription Registry. Int J Epidemiol. 2017;46(3):798-f.","journal-title":"Int J Epidemiol"},{"issue":"7 Suppl","key":"2817_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"HW Kildemoes","year":"2011","unstructured":"Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7 Suppl):38\u201341.","journal-title":"Scand J Public Health"},{"issue":"12","key":"2817_CR21","first-page":"B4360","volume":"58","author":"BM Norgard","year":"2011","unstructured":"Norgard BM. Birth outcome in women with ulcerative colitis and Crohn\u2019s disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Dan Med Bull. 2011;58(12):B4360.","journal-title":"Dan Med Bull"},{"key":"2817_CR22","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.2147\/CLEP.S278596","volume":"12","author":"A Broe","year":"2020","unstructured":"Broe A, Damkier P, Pottegard A, Hallas J, Bliddal M. Congenital Malformations in Denmark: Considerations for the Use of Danish Health Care Registries. Clin Epidemiol. 2020;12:1371\u201380.","journal-title":"Clin Epidemiol"},{"key":"2817_CR23","unstructured":"anomalies Eesoc. EUROCAT Guide 1.4, Section 3.2 Minor Anomalies and other conditions for Exclusion 2005. Available from: https:\/\/eu-rd-platform.jrc.ec.europa.eu\/system\/files\/public\/Section%203.2__22_11_2021.pdf."},{"issue":"7","key":"2817_CR24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1651-2227.1996.tb14164.x","volume":"85","author":"K Marsal","year":"1996","unstructured":"Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 1996;85(7):843\u20138.","journal-title":"Acta Paediatr"},{"issue":"8","key":"2817_CR25","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/j.1572-0241.2004.30472.x","volume":"99","author":"S Kane","year":"2004","unstructured":"Kane S, Kisiel J, Shih L, Hanauer S. HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. Am J Gastroenterol. 2004;99(8):1523\u20136.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2817_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"5","key":"2817_CR27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/apt.12412","volume":"38","author":"N Pedersen","year":"2013","unstructured":"Pedersen N, Bortoli A, Duricova D, DI R, Panelli MR, Gisbert JP, et al. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther. 2013;38(5):501\u201312.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"2817_CR28","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/bdra.23509","volume":"106","author":"AV Plauborg","year":"2016","unstructured":"Plauborg AV, Hansen AV, Garne E. Use of azathioprine and corticosteroids during pregnancy and birth outcome in women diagnosed with inflammatory bowel disease. Birth Defects Res A Clin Mol Teratol. 2016;106(6):494\u20139.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"6","key":"2817_CR29","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/MIB.0000000000001102","volume":"23","author":"H Kammerlander","year":"2017","unstructured":"Kammerlander H, Nielsen J, Kjeldsen J, Knudsen T, Friedman S, Norgard B. The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017;23(6):1011\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"2817_CR30","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.cgh.2010.02.014","volume":"8","author":"O Stephansson","year":"2010","unstructured":"Stephansson O, Larsson H, Pedersen L, Kieler H, Granath F, Ludvigsson JF, et al. Crohn\u2019s disease is a risk factor for preterm birth. Clin Gastroenterol Hepatol. 2010;8(6):509\u201315.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"2817_CR31","first-page":"1091","volume":"20","author":"G Broms","year":"2014","unstructured":"Broms G, Granath F, Linder M, Stephansson O, Elmberg M, Kieler H. Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure. Inflamm Bowel Dis. 2014;20(6):1091\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"2817_CR32","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1111\/j.1572-0241.2007.01355.x","volume":"102","author":"B Norgard","year":"2007","unstructured":"Norgard B, Hundborg HH, Jacobsen BA, Nielsen GL, Fonager K. Disease activity in pregnant women with Crohn\u2019s disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol. 2007;102(9):1947\u201354.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"2817_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/14767050410001668662","volume":"15","author":"MC Bush","year":"2004","unstructured":"Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med. 2004;15(4):237\u201341.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"2817_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129567","volume":"10","author":"HA Boyd","year":"2015","unstructured":"Boyd HA, Basit S, Harpsoe MC, Wohlfahrt J, Jess T. Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes. PLoS ONE. 2015;10(6): e0129567.","journal-title":"PLoS ONE"},{"issue":"3","key":"2817_CR35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.rdc.2017.04.013","volume":"43","author":"G Bandoli","year":"2017","unstructured":"Bandoli G, Palmsten K, Forbess Smith CJ, Chambers CD. A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes. Rheum Dis Clin North Am. 2017;43(3):489\u2013502.","journal-title":"Rheum Dis Clin North Am"},{"key":"2817_CR36","unstructured":"N\u00f8rg\u00e5rd BM. Birth outcome in women with ulcerative colitis and Crohn\u2019s disease, and pharmacoepidemiological aspects of antiinflammatory drug therapy [Doctoral dissertation]. University of Southern Denmark, Denmark: University of Southern Denmark, Denmark; 2011."},{"issue":"1","key":"2817_CR37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jaip.2020.07.047","volume":"9","author":"K Palmsten","year":"2021","unstructured":"Palmsten K, Bandoli G, Watkins J, Vazquez-Benitez G, Gilmer TP, Chambers CD. Oral Corticosteroids and Risk of Preterm Birth in the California Medicaid Program. J Allergy Clin Immunol Pract. 2021;9(1):375-84 e5.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"2817_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2020.100215","volume":"2","author":"SA Blankenship","year":"2020","unstructured":"Blankenship SA, Brown KE, Simon LE, Stout MJ, Tuuli MG. Antenatal corticosteroids in preterm small-for-gestational age infants: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(4): 100215.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"2817_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fnins.2013.00079","volume":"7","author":"JM Melville","year":"2013","unstructured":"Melville JM, Moss TJ. The immune consequences of preterm birth. Front Neurosci. 2013;7:79.","journal-title":"Front Neurosci"},{"issue":"12","key":"2817_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224766","volume":"14","author":"L Steiner","year":"2019","unstructured":"Steiner L, Diesner SC, Voitl P. Risk of infection in the first year of life in preterm children: An Austrian observational study. PLoS ONE. 2019;14(12): e0224766.","journal-title":"PLoS ONE"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02817-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-02817-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02817-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T10:07:45Z","timestamp":1681294065000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-02817-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2817"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-02817-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"31 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to Danish law and legislation, ethical review board approval or patient consent is not required for register-based studies. This study is approved by the Danish Data Protection Agency under the current joint notification of the Region of Southern Denmark (j.no. 19\u201311743). The representatives for patients and their relatives are part of the research council at our department, and the patient representatives have been involved in the research process, where they have been a part of the discussion about the research idea and which outcomes to measure. However, patient representatives were not involved in the methodological design of the study or in the manuscript writing process.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}